儿科COVID-19的免疫血栓和血纤维溶解功能:来自COVAC-TP试验的二次分析
Anthony A Sochet1,2,3, Austin R Sellers2, Marisol Betensky4,2,3
1Departments of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Blood vessels, thrombosis & hemostasis
|August 6, 2025
概括
炎症有助于血液凝结问题,并减少了COVID-19和MIS-C.住院的儿童的凝块分解. 这些发现突出了炎症.
科学领域:
- 儿科血液学 儿科血液学
- 传染性疾病 传染性疾病
- 临界护理医学 临界护理医学
背景情况:
- 儿科COVID-19中纤维溶解,炎症和前血栓风险之间的相互作用尚未得到充分理解.
- 儿童多系统炎症综合征 (MIS-C) 在评估血栓形成风险方面存在独特的挑战.
研究的目的:
- 研究与COVID-19和MIS-C.住院儿童的血纤维溶解能力和促炎性细胞因子度之间的关联.
- 为了确定细胞因子度是否因临床表型而异,并与纤维素分解 (低纤维素分解) 的受损相关.
主要方法:
- 对从儿童 (<18岁) 参与COVID-19抗凝剂在儿童-血栓预防试验的儿童储存的血样本的分析.
- 使用凝块形成和溶解 (CloFAL) 试验和修改的迷你欧球蛋白凝块溶解试验 (ECLA) 测量血凝结和纤维溶解功能.
- 使用Meso Scale发现试验和与纤维解析指数的相关性分析,对关键的促炎细胞因子 (IL-1β,IL-6,IL-8,TNF-α) 的量化.
主要成果:
- 观察到凝血功能的增加和纤维溶解功能的受损,特别是在MIS-C患者中.
- 血细胞因子度与低纤维素分解标志物 (升高的修饰型迷你ECLA CLTR和降低的CloFAL FI) 有显著的相关性.
结论:
- 炎症在COVID-19相关疾病的住院儿童中出现的高凝血和低纤维素溶解中起作用.
- 这些由炎症介导的静血变化可能会在这个儿科患者群体中导致前血栓风险.
相关概念视频
01:16Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
01:09Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
909
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
909
01:29Pulmonary Embolism I: Introduction
46
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
46